Type 2 Diabetics with long-standing hyperlipidemia
Conditions
Interventions
Atorvastatin:Atorvastatin Calcium Tablets,20 mg/d,8week
Fenofibrate:Fenofibrate Capsules,160mg/d,8week
Acipimox:Acipimox Capsules,500mg/d,8week
Sponsors
West China Hospital, Sichuan University
Eligibility
Sex/Gender
All
Age
30 Years to 75 Years
Inclusion criteria
Inclusion criteria: 1. Type 2 Diabtetics; 2. Patients with hyperlipidemia:TG>1.6mmol/L and/or TC>4.6mmol/L, and they didn't take antilipemic agents or steroid hormone at least three months before this trial; 3. we accept the patients between the ages of 30 and 75 years, who are still dyslipidaemia after one-month diet therapy.
Exclusion criteria
Exclusion criteria: 1. Hypothyroidism, Liver or Biliary Tract Diseases, Acute Myocardial Infarction during the last half year, Unstable Angina, Heart Failure, serious Renal Insufficiency or Kidney Failure and serious Cerebrovascular Trauma; 2. Drug induce Hyperlipidemia, Familial Hypercholesterolemia; 3. Having a major trauma , operation with intestines and stomach recently or the disease affecting drug absorbed; 4. Having Anaphylactic Reaction, Mental Disorders and Drinking history.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Serum lipids{TG,TC,LDL,HDL.Lp(a)};subgroup HDL; | — |
Secondary
| Measure | Time frame |
|---|---|
| BMI;HbA1; | — |
Countries
China
Contacts
Public ContactHaoming Tian
Outcome results
None listed